LncRNA多态和肺癌的风险
Esmat Abdi1, Saeid Latifi-Navid1, Alireza Panahi1
1Department of Biology, Faculty of Sciences, University of Mohaghegh Ardabili, Ardabil, 5619911367, Iran.
Personalized medicine
|November 2, 2023
概括
长非编码RNAs (lncRNAs) 的遗传变异显著影响肺癌 (LC) 的发展和治疗结果. 了解这些lncRNA多态可能有助于预测癌症风险,并为肺癌患者个性化治疗.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 肺癌 (LC) 是全球癌症相关死亡的主要原因.
- 在LC中经常观察到长非编码RNA (lncRNA) 的异常表达.
- lncRNA遗传多态性可以改变它们的表达和功能,影响癌症的进展.
研究的目的:
- 提供关于 lncRNA 遗传多态性对肺癌的影响的全面概述.
- 探索lncRNA变异在预测LC风险和治疗反应方面的潜力.
主要方法:
- 文献综述和现有关于lncRNA多态性和肺癌的研究的综合.
- 分析这些多态性如何影响癌症的发展,患者的存活率,化疗反应和复发.
主要成果:
- lncRNA遗传多态性与表达水平的改变和结构性功能障碍有关.
- 这些变异可以影响肺癌的关键方面,包括进展,存活率和治疗疗效.
- lncRNA变异显示出作为预测癌症风险和治疗结果的生物标志物的潜力.
结论:
- lncRNA遗传多态性在肺癌病原和临床结果中起着至关重要的作用.
- 需要进一步的大规模,多元化的种族研究来验证这些发现.
- 基于lncRNA基因型的个性化肺癌治疗是一种有前途的未来方向.
更多相关视频
相关概念视频
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Splicing
56.4K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.4K


